Inditreat
1 known investors
IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients. It is aimed at healthcare professionals and oncologists as a complement to traditional biomarker testing.
Investors · 1
Frequently asked questions
- What does Inditreat do?
- IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients. It is aimed at healthcare professionals and oncologists as a complement to traditional biomarker testing.
- Who are Inditreat's investors?
- Inditreat's investors include Kinled Holding.